BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 27357108)

  • 1. Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis.
    Søreide K; Watson MM; Lea D; Nordgård O; Søreide JA; Hagland HR;
    J Transl Med; 2016 Jun; 14(1):192. PubMed ID: 27357108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of CD133
    Fang C; Fan C; Wang C; Huang Q; Meng W; Yu Y; Yang L; Hu J; Li Y; Mo X; Zhou Z
    Cancer Med; 2017 Dec; 6(12):2850-2857. PubMed ID: 29105339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD133+CD54+CD44+ circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer.
    Fang C; Fan C; Wang C; Huang Q; Meng W; Yu Y; Yang L; Peng Z; Hu J; Li Y; Mo X; Zhou Z
    Oncotarget; 2016 Nov; 7(47):77389-77403. PubMed ID: 27764803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.
    Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
    Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.
    Pesta M; Fichtl J; Kulda V; Topolcan O; Treska V
    Anticancer Res; 2013 May; 33(5):2239-43. PubMed ID: 23645782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study.
    Bork U; Rahbari NN; Schölch S; Reissfelder C; Kahlert C; Büchler MW; Weitz J; Koch M
    Br J Cancer; 2015 Apr; 112(8):1306-13. PubMed ID: 25867263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Tumor Cells in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Clinical Utility for Long-Term Outcome: A Prospective Trial.
    Arrazubi V; Mata E; Antelo ML; Tarifa A; Herrera J; Zazpe C; Teijeira L; Viudez A; Suárez J; Hernández I; Vera R
    Ann Surg Oncol; 2019 Sep; 26(9):2805-2811. PubMed ID: 31209673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement.
    Nyström H; Tavelin B; Björklund M; Naredi P; Sund M
    Tumour Biol; 2015 Dec; 36(12):9839-47. PubMed ID: 26162539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
    Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
    Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology and significance of circulating and disseminated tumour cells in colorectal cancer.
    Steinert G; Schölch S; Koch M; Weitz J
    Langenbecks Arch Surg; 2012 Apr; 397(4):535-42. PubMed ID: 22350614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer.
    Watson MM; Lea D; Gudlaugsson E; Skaland I; Hagland HR; Søreide K
    Cancer Immunol Immunother; 2020 Aug; 69(8):1627-1637. PubMed ID: 32314040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) in Colorectal Cancer is Associated with an Elderly, Frail Phenotype and Improved Recurrence-Free Survival.
    Watson MM; Kanani A; Lea D; Khajavi RB; Søreide JA; Kørner H; Hagland HR; Søreide K
    Ann Surg Oncol; 2020 Apr; 27(4):1058-1067. PubMed ID: 31686344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastases.
    Lalmahomed ZS; Mostert B; Onstenk W; Kraan J; Ayez N; Gratama JW; Grünhagen D; Verhoef C; Sleijfer S
    Br J Cancer; 2015 Feb; 112(3):556-61. PubMed ID: 25562435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical utility of circulating tumour cells as biomarkers in cancer chemotherapy for advanced colorectal cancer.
    Otsuka K; Imai H; Soeda H; Komine K; Ishioka C; Shibata H
    Anticancer Res; 2013 Feb; 33(2):625-9. PubMed ID: 23393358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer.
    Barbazán J; Muinelo-Romay L; Vieito M; Candamio S; Díaz-López A; Cano A; Gómez-Tato A; Casares de Cal Mde L; Abal M; López-López R
    Int J Cancer; 2014 Dec; 135(11):2633-43. PubMed ID: 24752533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic biomarkers for metastatic colorectal cancer].
    Neumann JH
    Pathologe; 2016 Nov; 37(Suppl 2):180-185. PubMed ID: 27638531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.
    Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X
    Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
    Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M
    Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.
    Laghi L; Bianchi P; Miranda E; Balladore E; Pacetti V; Grizzi F; Allavena P; Torri V; Repici A; Santoro A; Mantovani A; Roncalli M; Malesci A
    Lancet Oncol; 2009 Sep; 10(9):877-84. PubMed ID: 19656725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DNA hypermethylation phenotype of colorectal cancer liver metastases resembles that of the primary colorectal cancers.
    Orjuela S; Menigatti M; Schraml P; Kambakamba P; Robinson MD; Marra G
    BMC Cancer; 2020 Apr; 20(1):290. PubMed ID: 32252665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.